Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kenneth R Hess
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
1986
Papers
438
H Index
98
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37114244
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Neurooncol Adv
2023
37114244
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Neurooncol Adv
2023
36989609
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
J Clin Oncol
2023
36989609
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
J Clin Oncol
2023
32763059
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.
Acad Radiol
2022
32763059
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area.
Acad Radiol
2022
34538550
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.
Acad Radiol
2022
34538550
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.
Acad Radiol
2022
32920733
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Breast Cancer Res Treat
2021
31924662
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
BMJ Support Palliat Care
2021
32033821
Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.
Curr Probl Diagn Radiol
2021
33721621
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.
ESMO Open
2021
34342274
Structural and spectrophotometric investigation of two unnatural amino-acid altered chromophores in the superfolder green fluorescent protein.
Acta Crystallogr D Struct Biol
2021
32920733
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Breast Cancer Res Treat
2021
33289280
High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.
Oncologist
2021
34965510
Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
J Natl Compr Canc Netw
2021
34377987
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Neurooncol Adv
2021
33721621
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.
ESMO Open
2021
34965510
Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
J Natl Compr Canc Netw
2021
34377987
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Neurooncol Adv
2021
34342274
Structural and spectrophotometric investigation of two unnatural amino-acid altered chromophores in the superfolder green fluorescent protein.
Acta Crystallogr D Struct Biol
2021
32033821
Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.
Curr Probl Diagn Radiol
2021
31924662
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
BMJ Support Palliat Care
2021
33289280
High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.
Oncologist
2021
31076332
Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.
Acad Radiol
2020
32080210
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies.
Sci Rep
2020
31852833
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.
Clin Cancer Res
2020
32195353
Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.
Sci Adv
2020
32195033
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.
Am J Cancer Res
2020
32423453
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
BMC Cancer
2020
32191331
Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
JAMA Netw Open
2020
32188704
Phase 2 study of pembrolizumab in patients with advanced rare cancers.
J Immunother Cancer
2020
32303619
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors.
J Immunother Cancer
2020
32298794
Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data.
Pract Radiat Oncol
2020
32108973
The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings.
Breast J
2020
31932214
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.
Pancreatology
2020
32219153
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice.
NPJ Breast Cancer
2020
31605794
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
J Thorac Oncol
2020
33097651
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
ESMO Open
2020
33097611
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.
J Immunother Cancer
2020
32868897
Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials.
Br J Cancer
2020
32529146
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation.
Adv Radiat Oncol
2020
32747747
Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.
Br J Cancer
2020
32916308
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
J Thorac Oncol
2020
33114311
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer.
Cancers (Basel)
2020
32777736
Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.
Eur J Radiol
2020
33051340
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
J Immunother Cancer
2020
31076332
Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.
Acad Radiol
2020
31371208
Variation in Technical Quality of Breast MRI.
Acad Radiol
2020
31311772
Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle Biopsy.
Acad Radiol
2020
1 - 50 of 876
Column Actions
Search
Recommended Authors
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Career Start Year
2009
Number of shared co-authors
4
Mark E Smolkin
University of Virginia
Career Start Year
2002
Number of shared co-authors
3
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
12
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
3
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year
2001
Number of shared co-authors
6
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
1
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
0
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year
1999
Number of shared co-authors
5
Thomas J George
UF Health Cancer Center
Career Start Year
1998
Number of shared co-authors
23
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
7
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
7
Nam Bui
Stanford University
Career Start Year
1996
Number of shared co-authors
1
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
10
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1994
Number of shared co-authors
3
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
6
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
6
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year
1993
Number of shared co-authors
2
Vera J Suman
Mayo Clinic
Career Start Year
1992
Number of shared co-authors
11
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year
1992
Number of shared co-authors
1
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year
1991
Number of shared co-authors
2
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
6
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
3
Joan Albanell
Hospital del Mar Research Institute
Career Start Year
1990
Number of shared co-authors
14
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year
1990
Number of shared co-authors
11
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
5
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year
1988
Number of shared co-authors
2
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year
1985
Number of shared co-authors
8
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year
1984
Number of shared co-authors
6
Helen J Ross
Mayo Clinic
Career Start Year
1982
Number of shared co-authors
3
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year
1974
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers
49
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers
46
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers
37
Lajos Pusztai
Co-authored papers
33
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers
26
William F Symmans
Co-authored papers
24
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Co-authored papers
20
Morris D Groves
The University of Texas MD Anderson Cancer Center
Co-authored papers
19
Michael D Prados
University of California san francisco
Co-authored papers
17
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers
17
Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers
16
Gary J Whitman
Co-authored papers
16
Kenneth Aldape
National Cancer Institute
Co-authored papers
15
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
12
Shubham Pant
The University of Texas MD Anderson Cancer Center
Co-authored papers
11
John G Kuhn
Co-authored papers
10
David Schiff
University of Virginia School of Medicine
Co-authored papers
9
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
9
Minesh P Mehta
Co-authored papers
9
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers
9
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers
8
John F de Groot
Co-authored papers
8
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers
7
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers
7
Thomas A Buchholz
Co-authored papers
7
Erik P Sulman
NYU Grossman School of Medicine
Co-authored papers
7
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Co-authored papers
7
Patrick Y Wen
Co-authored papers
7
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
6
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
6
1 - 30